Health
Buck researchers investigate ketone bodies as possible therapeutic against COVID-19 – News-Medical.Net
Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician J…
Reviewed by Emily Henderson, B.Sc.Jul 15 2020
Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.
…
-
General23 hours agoDonald Trump pardons Rudy Giuliani and others involved in trying to overturn 2020 election
-
General15 hours agoMillennials and Gen Z voters continued shift away from Coalition in 2025
-
General11 hours agoTyphoon Fung-wong leaves eight dead and 1.4 million displaced in Philippines
-
Business15 hours agoWhere to invest $5,000 in ASX ETFs in November